Rwanda has approved the production of medical cannabis strictly for export, seeking to target fast-growing markets in the United States and European Union, even though its use remains illegal at home.
Guidelines for the production and export of medical cannabis were approved by the cabinet on Monday, and a government statement said Wednesday that it would not change strict local laws around marijuana consumption.
“Rwanda will begin to receive applications for licenses from interested investors for this high-value therapeutic crop. This investment framework does not affect the legal status of cannabis consumption in Rwanda, which remains prohibited,” the statement said.
The Rwanda Development Board said several companies have tendered bids to begin mass production, as the tiny East African nation seeks a slice of the multi-billion-dollar medical cannabis market.
“We have interested investors that we are going to work with for the next few days now that we have guidelines in place to see how Rwanda can contribute to medicinal research in…